Patents by Inventor Javier Szwarcberg

Javier Szwarcberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF ADMINISTERING PIRFENIDONE THERAPY
    Publication number: 20200038387
    Abstract: The present invention relates to methods involving avoiding adverse drug interactions with fluvoxamine and pirfenidone or other moderate to strong inhibitors of CYP enzymes.
    Type: Application
    Filed: October 10, 2019
    Publication date: February 6, 2020
    Inventors: Williamson Z. Bradford, Javier Szwarcberg
  • PIRFENIDONE TREATMENT FOR PATIENTS WITH ATYPICAL LIVER FUNCTION
    Publication number: 20190314351
    Abstract: Methods are provided for administering pirfenidone to a patient that has exhibited abnormal biomarkers of liver function in response to pirfenidone administration. The methods include administering to a patient pirfenidone at doses lower than the full target dosage for a time period, followed by administering to the patient pirfenidone at the full target dosage. The methods also include administering pirfenidone at the full target dose with no reduction and administering permanently reduced doses of pirfenidone.
    Type: Application
    Filed: June 21, 2019
    Publication date: October 17, 2019
    Inventors: Williamson Z. Bradford, Javier Szwarcberg
  • METHODS OF ADMINISTERING PIRFENIDONE THERAPY
    Publication number: 20190183872
    Abstract: The present invention relates to methods involving avoiding adverse drug interactions with fluvoxamine and pirfenidone or other moderate to strong inhibitors of CYP enzymes.
    Type: Application
    Filed: February 22, 2019
    Publication date: June 20, 2019
    Inventors: Williamson Z. Bradford, Javier Szwarcberg
  • Pirfenidone Treatment for Patients with Atypical Liver Function
    Publication number: 20190060299
    Abstract: Methods are provided for administering pirfenidone to a patient that has exhibited abnormal biomarkers of liver function in response to pirfenidone administration. The methods include administering to a patient pirfenidone at doses lower than the full target dosage for a time period, followed by administering to the patient pirfenidone at the full target dosage. The methods also include administering pirfenidone at the full target dose with no reduction and administering permanently reduced doses of pirfenidone.
    Type: Application
    Filed: October 31, 2018
    Publication date: February 28, 2019
    Inventors: Williamson Z. Bradford, Javier Szwarcberg
  • METHODS OF ADMINISTERING PIRFENIDONE THERAPY
    Publication number: 20180311221
    Abstract: The present invention relates to methods involving avoiding adverse drug interactions with fluvoxamine and pirfenidone or other moderate to strong inhibitors of CYP enzymes.
    Type: Application
    Filed: June 27, 2018
    Publication date: November 1, 2018
    Inventors: Williamson Z. Bradford, Javier Szwarcberg
  • Pirfenidone Treatment for Patients with Atypical Liver Function
    Publication number: 20180200242
    Abstract: Methods are provided for administering pirfenidone to a patient that has exhibited abnormal biomarkers of liver function in response to pirfenidone administration. The methods include administering to a patient pirfenidone at doses lower than the full target dosage for a time period, followed by administering to the patient pirfenidone at the full target dosage. The methods also include administering pirfenidone at the full target dose with no reduction and administering permanently reduced doses of pirfenidone.
    Type: Application
    Filed: March 12, 2018
    Publication date: July 19, 2018
    Inventors: Williamson Z. Bradford, Javier Szwarcberg
  • METHODS OF ADMINISTERING PIRFENIDONE THERAPY
    Publication number: 20180064695
    Abstract: The present invention relates to methods involving avoiding adverse drug interactions with fluvoxamine and pirfenidone or other moderate to strong inhibitors of CYP enzymes.
    Type: Application
    Filed: November 10, 2017
    Publication date: March 8, 2018
    Inventors: Williamson Z. Bradford, Javier Szwarcberg
  • PIRFENIDONE TREATMENT FOR PATIENTS WITH ATYPICAL LIVER FUNCTION
    Publication number: 20170333411
    Abstract: Methods are provided for administering pirfenidone to a patient that has exhibited abnormal biomarkers of liver function in response to pirfenidone administration. The methods include administering to a patient pirfenidone at doses lower than the full target dosage for a time period, followed by administering to the patient pirfenidone at the full target dosage. The methods also include administering pirfenidone at the full target dose with no reduction and administering permanently reduced doses of pirfenidone.
    Type: Application
    Filed: August 4, 2017
    Publication date: November 23, 2017
    Inventors: Williamson Z. Bradford, Javier Szwarcberg
  • Methods of Administering Pirfenidone Therapy
    Publication number: 20170128429
    Abstract: The present invention relates to methods involving avoiding adverse drug interactions with fluvoxamine and pirfenidone or other moderate to strong inhibitors of CYP enzymes.
    Type: Application
    Filed: January 23, 2017
    Publication date: May 11, 2017
    Inventors: Williamson Z. Bradford, Javier Szwarcberg
  • PIRFENIDONE TREATMENT FOR PATIENTS WITH ATYPICAL LIVER FUNCTION
    Publication number: 20170100381
    Abstract: Methods are provided for administering pirfenidone to a patient that has exhibited abnormal biomarkers of liver function in response to pirfenidone administration. The methods include administering to a patient pirfenidone at doses lower than the full target dosage for a time period, followed by administering to the patient pirfenidone at the full target dosage. The methods also include administering pirfenidone at the full target dose with no reduction and administering permanently reduced doses of pirfenidone.
    Type: Application
    Filed: December 22, 2016
    Publication date: April 13, 2017
    Inventors: Williamson Z. Bradford, Javier Szwarcberg
  • Methods of Administering Pirfenidone Therapy
    Publication number: 20160303098
    Abstract: The present invention relates to methods involving avoiding adverse drug interactions with fluvoxamine and pirfenidone or other moderate to strong inhibitors of CYP enzymes.
    Type: Application
    Filed: June 10, 2016
    Publication date: October 20, 2016
    Inventors: Williamson Z. Bradford, Javier Szwarcberg
  • Pirfenidone Treatment for Patients with Atypical Liver Function
    Publication number: 20160250198
    Abstract: Methods are provided for administering pirfenidone to a patient that has exhibited abnormal biomarkers of liver function in response to pirfenidone administration. The methods include administering to a patient pirfenidone at doses lower than the full target dosage for a time period, followed by administering to the patient pirfenidone at the full target dosage. The methods also include administering pirfenidone at the full target dose with no reduction and administering permanently reduced doses of pirfenidone.
    Type: Application
    Filed: May 6, 2016
    Publication date: September 1, 2016
    Inventors: Williamson Z. Bradford, Javier Szwarcberg
  • PIRFENIDONE THERAPY AND INDUCERS OF CYTOCHROME P450
    Publication number: 20150342941
    Abstract: The present invention relates to methods involving avoiding adverse drug interactions with pirfenidone and CYP inducers, such as smoking.
    Type: Application
    Filed: August 13, 2015
    Publication date: December 3, 2015
    Inventors: Williamson Z. Bradford, Javier Szwarcberg
  • PIRFENIDONE THERAPY AND INDUCERS OF CYTOCHROME P450
    Publication number: 20150111899
    Abstract: The present invention relates to methods involving avoiding adverse drug interactions with pirfenidone and CYP inducers, such as smoking.
    Type: Application
    Filed: December 23, 2014
    Publication date: April 23, 2015
    Inventors: Williamson Z. Bradford, Javier Szwarcberg
  • Methods of Administering Pirfenidone Therapy
    Publication number: 20140350060
    Abstract: The present invention relates to methods involving avoiding adverse drug interactions with fluvoxamine and pirfenidone or other moderate to strong inhibitors of CYP enzymes.
    Type: Application
    Filed: August 8, 2014
    Publication date: November 27, 2014
    Inventors: Williamson Z. Bradford, Javier Szwarcberg
  • Pirfenidone therapy and inducers of cytochrome P450
    Patent number: 8754109
    Abstract: The present invention relates to methods involving avoiding adverse drug interactions with pirfenidone and CYP inducers, such as smoking.
    Type: Grant
    Filed: December 3, 2010
    Date of Patent: June 17, 2014
    Assignee: Intermune, Inc.
    Inventors: Williamson Z. Bradford, Javier Szwarcberg
  • Pirfenidone therapy and inducers of cytochrome P450
    Patent number: 8648098
    Abstract: The present invention relates to methods involving avoiding adverse drug interactions with pirfenidone and CYP inducers, such as smoking.
    Type: Grant
    Filed: December 15, 2011
    Date of Patent: February 11, 2014
    Assignee: Intermune, Inc.
    Inventors: Williamson Ziegler Bradford, Javier Szwarcberg
  • Pirfenidone treatment for patients with atypical liver function
    Patent number: 8609701
    Abstract: Methods are provided for administering pirfenidone to a patient that has exhibited abnormal biomarkers of liver function in response to pirfenidone administration. The methods include administering to a patient pirfenidone at doses lower than the full target dosage for a time period, followed by administering to the patient pirfenidone at the full target dosage. The methods also include administering pirfenidone at the full target dose with no reduction and administering permanently reduced doses of pirfenidone.
    Type: Grant
    Filed: November 9, 2009
    Date of Patent: December 17, 2013
    Assignee: Intermune, Inc.
    Inventors: Williamson Ziegler Bradford, Javier Szwarcberg
  • Pirfenidone treatment for patients with atypical liver function
    Patent number: 8592462
    Abstract: Methods are provided for administering pirfenidone to a patient that has exhibited abnormal biomarkers of liver function in response to pirfenidone administration. The methods include administering to a patient pirfenidone at doses lower than the full target dosage for a time period, followed by administering to the patient pirfenidone at the full target dosage. The methods also include administering pirfenidone at the full target dose with no reduction and administering permanently reduced doses of pirfenidone.
    Type: Grant
    Filed: December 6, 2011
    Date of Patent: November 26, 2013
    Assignee: Intermune, Inc.
    Inventors: Williamson Ziegler Bradford, Javier Szwarcberg
  • PIRFENIDONE THERAPY AND INDUCERS OF OF CYTOCHROME P450
    Publication number: 20130045997
    Abstract: The present invention relates to methods involving avoiding adverse drug interactions with pirfenidone and CYP inducers, such as smoking.
    Type: Application
    Filed: December 3, 2010
    Publication date: February 21, 2013
    Applicant: INTERMUNE, INC
    Inventors: Williamson Z. Bradford, Javier Szwarcberg